ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,112Medicare Part D Prescriptions Filled, Including Refills

Rank: 249 out of 1185

$479K Total Retail Price of All Prescriptions

Rank: 293 out of 1185

307 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 307 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,593 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 357 327 1 1
LISINOPRIL 352 320 2 4
HYDROCHLOROTHIAZIDE 332 325 3 12
LEVOTHYROXINE SODIUM 299 297 4 3
METOPROLOL TARTRATE 291 276 5 10
POTASSIUM CHLORIDE 259 255 6 18
FUROSEMIDE 259 254 6 8
OMEPRAZOLE 248 230 8 6
DONEPEZIL HCL 232 232 9 32
PRAVASTATIN SODIUM 231 209 10 7
WARFARIN SODIUM 213 201 11 21
METFORMIN HCL 201 198 12 9
SIMVASTATIN 154 151 13 5
METOPROLOL SUCCINATE 143 130 14 20
RANITIDINE HCL 138 133 15 17
NAMENDA 123 123 16 43
DIOVAN 107 101 17 37
CLOPIDOGREL 103 99 18 31
BENAZEPRIL HCL 102 102 19 41
GABAPENTIN 101 84 20 13
LOVASTATIN 98 81 21 63
ATORVASTATIN CALCIUM 97 79 22 11
TRAZODONE HCL 96 81 23 38
LOSARTAN POTASSIUM 87 87 24 26
CARVEDILOL 86 86 25 24
ADVAIR DISKUS 76 76 26 54
TRIAMTERENE-HCTZ 75 60 27 71
CLONIDINE HCL 73 57 28 47
PLAVIX 72 69 29 45
ALLOPURINOL 70 70 30 30
CRESTOR 69 69 31 23
LANTUS 68 64 32 66
MIRTAZAPINE 66 66 33 57
FLUTICASONE PROPIONATE 64 54 34 29
ATENOLOL 62 60 35 28
SERTRALINE HCL 58 54 36 25
CALCITONIN-SALMON 58 58 36 314
ISOSORBIDE MONONITRATE ER 58 58 36 48
PANTOPRAZOLE SODIUM 56 54 39 58
ROPINIROLE HCL 55 55 40 108
NOVOLOG 54 48 41 127
COLCRYS 53 53 42 110
RISPERIDONE 53 53 42 72
PREDNISONE 52 44 44 33
DILTIAZEM 24HR CD 51 51 45 123
TRAMADOL HCL 51 51 45 16
CAPTOPRIL 51 51 45 242
QUETIAPINE FUMARATE 51 47 45 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.